SMARCB1 is required for widespread BAF complex–mediated activation of enhancers and bivalent promoters
Robert Nakayama(Harvard University), Cigall Kadoch(Broad Institute), Christina Williamson(Harvard University), Christian J. Widmer(Harvard University), George D. Demetri(American Society of Clinical Oncology), Wai Lim Ku(National Institutes of Health), Jeffrey A. Ranish(Institute for Systems Biology), Keji Zhao(National Institutes of Health), Mingxiang Teng(Dana-Farber Cancer Institute), Rafael A. Irizarry(Dana-Farber Cancer Institute), Matthew J. McBride(Broad Institute), Alfredo M. Valencia(Neurosciences Institute), Mark A. Gillespie(Institute for Systems Biology), Zachary M. McKenzie(Harvard University), He Qing(Harvard University), Seth H. Cassel(Broad Institute), Kairong Cui(National Institutes of Health), John L. Pulice(Broad Institute)
Cited by 296
Related Papers
A framework for oligonucleotide microarray preprocessing
|Bioinformatics|2010|1.6k
Accounting for cellular heterogeneity is critical in epigenome-wide association studies
|Genome biology|2014|1.2k
Meta-analysis of gut microbiome studies identifies disease-specific and shared responses
|Nature Communications|2017|1k